| 2024 | 2023 | 2023 | 2022 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 74,6 k € | +79.7% | 41,5 k € | -53.0% | 88,3 k € | +0.4% | 88,0 k € | +42.4% | 61,8 k € | -31.4% | 90,0 k € | +175.0% | 32,7 k € | -52.4% | 68,8 k € | -25.4% | 92,2 k € | -26.6% | 125,6 k € | +32.6% | 94,8 k € | -3.7% | 98,4 k € | +85.1% | 53,2 k € | +7.5% | 49,5 k € | +61.4% | 30,6 k € | |
| EBITDA | 72,3 k € | +81.8% | 39,8 k € | -53.2% | 85,0 k € | +0.2% | 84,9 k € | +42.0% | 59,8 k € | -32.2% | 88,2 k € | +174.0% | 32,2 k € | -52.8% | 68,2 k € | -25.1% | 91,1 k € | -26.7% | 124,3 k € | +34.7% | 92,3 k € | +10.1% | 83,8 k € | +77.2% | 47,3 k € | -3.3% | 48,9 k € | +62.1% | 30,2 k € | |
| Operating profit | 51,7 k € | +120.3% | 23,5 k € | -61.1% | 60,3 k € | -1.2% | 61,0 k € | +196.0% | 20,6 k € | -60.3% | 52,0 k € | +1669.7% | 2,9 k € | -80.3% | 14,9 k € | -58.9% | 36,3 k € | -55.4% | 81,4 k € | +86.6% | 43,6 k € | -7.6% | 47,2 k € | +1158.7% | 3,7 k € | -72.6% | 13,7 k € | +2789.7% | -508,6 € | |
| Profit/loss | 32,2 k € | +100.9% | 16,1 k € | -58.0% | 38,2 k € | +1.2% | 37,8 k € | +350.4% | 8,4 k € | -69.9% | 27,9 k € | +677.6% | -4,8 k € | -1354.4% | 384,4 € | -97.7% | 17,0 k € | -67.1% | 51,9 k € | +109.9% | 24,7 k € | -7.5% | 26,7 k € | +692.9% | -4,5 k € | -158.2% | 7,7 k € | +452.3% | -2,2 k € | |
| Equity | 330,1 k € | +7.8% | 306,3 k € | -3.7% | 318,1 k € | +13.7% | 279,9 k € | +69.1% | 165,5 k € | +5.3% | 157,1 k € | +21.5% | 129,3 k € | -3.6% | 134,1 k € | +0.3% | 133,7 k € | +14.6% | 116,7 k € | +80.0% | 64,8 k € | +61.6% | 40,1 k € | +198.6% | 13,4 k € | -25.1% | 17,9 k € | +75.8% | 10,2 k € | |
| Total assets | 521,7 k € | -5.4% | 551,7 k € | -1.1% | 557,6 k € | -3.6% | 578,2 k € | +15.7% | 499,9 k € | +5.4% | 474,2 k € | +11.2% | 426,6 k € | -9.5% | 471,6 k € | -6.6% | 504,7 k € | +99.1% | 253,5 k € | +15.2% | 220,1 k € | +5.6% | 208,4 k € | -2.8% | 214,3 k € | -2.4% | 219,7 k € | -14.6% | 257,3 k € | |
| Cash | 14,5 k € | +94.6% | 7,4 k € | -79.3% | 35,9 k € | -19.0% | 44,3 k € | +162.4% | 16,9 k € | -27.7% | 23,4 k € | -9.9% | 25,9 k € | +26.2% | 20,6 k € | -30.0% | 29,4 k € | -48.0% | 56,4 k € | +61.4% | 35,0 k € | -37.7% | 56,1 k € | +278.9% | 14,8 k € | -21.6% | 18,9 k € | -25.2% | 25,2 k € | |
| Debts | 191,6 k € | -22.0% | 245,5 k € | +2.5% | 239,5 k € | -19.7% | 298,3 k € | -10.8% | 334,3 k € | +5.4% | 317,1 k € | +6.7% | 297,3 k € | -11.9% | 337,4 k € | -9.0% | 371,0 k € | +171.1% | 136,8 k € | -11.9% | 155,3 k € | -7.7% | 168,3 k € | -16.2% | 200,9 k € | -0.4% | 201,7 k € | -18.4% | 247,1 k € | |
Private limited company · Bree · incorporated on 22/05/2008
Private limited company profitable and well capitalised. Cash position rising (+94.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DOKTER KRISTOF JEUNEN is a Private limited company incorporated in 2008. Its main activity is: Other human health activities. Its registered office is in Bree.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette